Antifungal drugs Dr. Raz Muhammed

Similar documents
Fungi are eukaryotic With rigid cell walls composed largely of chitin rather than peptidoglycan (a characteristic component of most bacterial cell

Antifungal Agents. Prof. Suheil Zmeili Faculty of Medicine Department of Pharmacology University of Jordan

ANTIMYCOTIC DRUGS Modes of Action

Antimycotics. November 14, Jan Strojil. Ústav farmakologie LF UP

Pharmaceutical Chemistry II. Antifungal Agents. = Antimycotics. Tutorial 1

Course content. Chemotherapeutic agents

Antifungal Agents. Polyenes Azoles Allyl and Benzyl Amines Other antifungals

(Notes on Anti-TB agents are included in the TB syllabus)

PHARMACEUTICAL CHEMISTRY II (PHCM672) Lecture 1, Antifungal Drugs (Antimycotics) Dr. Mohammad Abdel-Halim

ANTIFUNGAL AGENTS. Alison Clode, DVM, DACVO. Port City Veterinary Referral Hospital Portsmouth, New Hampshire

Management of fungal infection

Biochemical Targets for Antifungal Chemotherapy

Antifungal Drugs 35 I. OVERVIEW II. DRUGS FOR SUBCUTANEOUS AND SYSTEMIC MYCOTIC INFECTIONS

Antimicrobials; antibacterials, antifungals, antiprotozoans, antivirals, and antihelminthics 6

Drugs dermatological conditions II

Biochemical Targets for Antifungal Chemotherapy

Itraconazole DIGICON. Composition: MOLECULAR INTRODUCTION

Antifungals, antivirals, antiprotozoals, and anthelmintics

Chapter III ANTIVIRAL AND ANTIFUNGAL DRUGS

Clinical Practice Guideline Superficial Fungal Infection

Med Chem 401: Mycology ( Mycology

About the Editor Gerri S. Hall, Ph.D.

Special features. For personal use only. Not to be reproduced without permission of the editor

Updated Guidelines for Management of Candidiasis. Vidya Sankar, DMD, MHS April 6, 2017

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory ZODERM E CREAM. Oxiconazole Nitrate Cream

Antifungal resistance mechanisms in pathogenic fungi

LUZU (luliconazole) external cream

Dr Hamed Alzoubi. Fungal infections

Antifungal therapies differences in agents

Improving Clinical Outcomes in Fungal Infection Control and Management

Current Options in Antifungal Pharmacotherapy

CURRENT AND NEWER ANTI-FUNGAL THERAPIES- MECHANISMS, INDICATIONS, LIMITATIONS AND PROBLEMS. Dr AMIT RAODEO DM SEMINAR

number Done by Corrected by Doctor

SUSCEPTIBILITY PROFILE OF EMERGING FUNGAL PATHOGENS

Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens

Common Fungi. Catherine Diamond MD MPH

Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance

Ali Alabbadi. Sarah Jaar ... Nader

B. Incorrect! Peginterferon α-2a is used for the treatment of chronic hepatitis B and may be preferable to interferon- α.

Prophylaxis versus Diagnostics-driven approaches to treatment of Invasive fungal diseases. Y.L. Kwong Department of Medicine University of Hong Kong

FLUCAND HIKMA PHARMACEUTICALS

Cigna Drug and Biologic Coverage Policy

Fungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia

Current and Emerging Azole Antifungal Agents

ITRANOX. Composition Each capsule contains :

number Done by Corrected by Doctor د.حامد الزعبي

C. albicans C. tropicalis C. parapsilosis C. kefyr C. glabrata C. krusei C. guillermondii C. lusitaniae THERAPY USING ANTIFUNGALS AND ANTIVIRALS

Summary of Product Characteristics

number Done by Corrected by Doctor

The sensitivity of fungal microorganisms to fluconazole is as follows:

Deep Dermatophytosis

Antifungals and current treatment guidelines in pediatrics and neonatology

DISEASES OF FUNGAL ORIGIN

THE TREATMENT OF MYCOSES IN REPTILES: A REVIEW OF ANTIFUNGAL DRUGS

Pharmacogenomics of Antifungal Agents

1. NAME OF THE MEDICINAL PRODUCT. Lamisil 1% cutaneous solution. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Mycology. Dr. Agoston Ghidan

Malaria prevention: source = The Sanford Guide to Antimicrobial Therapy. Gilbert et al.

Nursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi Medical Microbiology

IJBCP International Journal of Basic & Clinical Pharmacology

Fungal Infections. Alessandro Diana November 22th 2007

Rheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement

Bloodborne Pathogens. Introduction to Fungi. Next >> COURSE 2 MODULE 4

Sumyuktha J., Murali Narasimhan*, Parveen Basher Ahamed

Antifungal Update 2/22/12. Which is the most appropriate initial empirical therapy in a candidemic patient?

TINEA (FUNGAL) INFECTION

Antifungal Update 2/24/11. Which is the most appropriate initial empirical therapy in a candidemic patient?

An Update in the Management of Candidiasis

Tinea: Head to Toe A dermatophyte tour of human skin. Tour de Tinea Head to Toe. Tips for Tinea Head to Toe. Psoriasis. Non-inflammatory Tinea Capitis

Case Studies in Fungal Infections and Antifungal Therapy

FORCAN Fluconazole tablets and injections. COMPOSITION Forcan-50 tablets Fluconazole USP mg. Forcan-150 tablets Fluconazole USP...

Antifungal Update. Candida: In Vitro Antifungal Susceptibility Testing

SUMMARY OF PRODUCT CHARACTERISTICS

Common Superficial Fungal Infections

Fungi. Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy:

Review Article Antifungal Resistance and New Strategies to Control Fungal Infections

Medicinal Chemistry I II nd Module Special Section (3) Major Antifungal Drugs

The incidence of invasive fungal infections

Fungal Infection in the ICU: Current Controversies

Three clinical cases. fungal infections

البيض بالمبيضات الحفاظي الجلد التهاب = candidiasis Diaper

Outline Dermatomycoses Definition: diseases or fungal infections of the skin Transmission of Dermatomycoses Case Report 1 Presentation of Disease

NEW ANTI-INFECTIVE AGENTS IN 2003 : SPECTRUM AND INDICATIONS. 20th Symposium (spring 2003) Thursday May 22nd 2003

Voriconazole. Voriconazole VRCZ ITCZ

New antifungal agents

Naf tifine: A Topical Allylamine Antifungal Agent

Medical Management of Fungal Sinusitis

Updates and practical guide on antifungal agents

CANESPOR CREAM CANESPOR SOLUTION

Introduction. Yeast candida, cryptococcus, trichosporon. Filamentous rhizopus, rhizomucor, mucor. Dimorphic Fungi bl t hi t l

Fungal update. Liise-anne Pirofski, M.D. Albert Einstein College of Medicine

Opportunistic Mycoses

VISHALKSHI VISHWANATH AND NITI KHUNGER

Antibiotics derived from the acetate metabolism

Dermatophytie = ﺔﻔﻌﺳ ﺔﻴرﻄﻓ

Catamaran Prior Authorization Department. Phone: Fax: Prescriber Information. Member Information.

Novel Antifungal Activity of Geraniol and its Synergistic Effect in Combination with Fluconazole Against Resistant Candida albicans

Dermatology for the Internist DREW M ANDERSON, MD VOLUNTEER CLINICAL ASSISTANT PROFESSOR OF MEDICINE, INDIANA UNIVERSITY SCHOOL OF MEDICINE

Assistant Professor 2 Professor, Department of Pharmacology, Govt. Stanley Medical College& Hospital, Chennai, Tamilnadu, India

Transcription:

Antifungal drugs 13. 12. 2018 Dr. Raz Muhammed

2. Flucytosine (5-FC) Is fungistatic Is a synthetic pyrimidine antimetabolite Is often used in combination with amphotericin B in the treatment of systemic mycoses and for meningitis caused by Cryptococcus neoformans and Candida albicans Amphotericin B increases cell permeability, allowing more 5-FC to penetrate the cell / synergistic.

Mechanism of action: 5-FC enters fungal cells via a cytosine-specific permease an enzyme not found in mammalian cells. 5-FC is then converted by a series of steps to a false nucleotide (5-FdUMP) this false nucleotide inhibits thymidylate synthase.

Thus depriving the organism of thymidylic acid ( an essential DNA component). The unnatural mononucleotide is further metabolized to a trinucleotide & is incorporated into fungal RNA, where it disrupts nucleic acid and protein synthesis.

Pharmacokinetics: well absorbed by oral route Toxicity: 1. Reversible bone marrow depression, 2. Alopecia 3. Liver dysfunction

3. Azole antifungal agents -Ketoconazole -Fluconazole -Itraconazole -Voriconazole -Posaconazole (new)

Mechanism of action: Azoles are fungistatic. The azoles interfere with fungal cell membrane permeability by inhibiting the synthesis of ergosterol. These drugs inhibit of lanosterol 14 alpha demethylase, the enzyme necessary to convert lanosterol to ergosterol. This inhibition disrupts membrane structure and function so inhibits fungal cell growth.

Ketoconazole Narrow antifungal spectrum it is now rarely used for systemic mycoses. Used for chronic mucocutaneous candidiasis Orally is effective against dermatophytes Although penetration into tissues is limited, it is effective in the treatment of histoplasmosis in lung, bone, skin, and soft tissues.

Topical ketoconazole is used to treat : 1. tinea corporis, tinea cruris, and tinea pedis 2. seborrheic dermatitis 3. dandruff.

Ketoconazole Pharmacokinetics When taken orally it requires gastric acid for dissolution and is absorbed through the gastric mucosa The absorption of ketoconazole is impaired when taken with: antacids H2-histamine receptor blockers proton-pump inhibitors

Adverse effects: Allergies, dose-dependent GIT disturbances, Endocrine effects ( gynecomastia, decreased libido, impotence, menstrual irregularities) in addition to blocking fungal ergosterol synthesis, also inhibits human gonadal and adrenal steroid synthesis, leading to decreased testosterone and cortisol production. ketoconazole inhibits CYP450 enzymes.

Drug interactions and contraindications: By inhibiting cytochrome P450, ketoconazole potentiate the toxicities phenytoin, tolbutamide & warfarin. Rifampin is an inducer of the cytochrome P450 system shorten the duration of action of ketoconazole. Contraindicated in pregnancy

Fluconazole Clinically important Why? Because it lacks of the endocrine side effects of ketoconazole, Its excellent penetrability into the CSF of both normal and inflamed meninges.

Clinical uses Drug of choice in esophageal & oropharyngeal candidiasis A single oral dose eradicates vaginal candidiasis Drug of choice for initial & secondary prophylaxis against cryptococcal meningitis.

Itraconazole It has a broad antifungal spectrum Itraconazole is well absorbed orally, but it requires acid for dissolution.

Is used in treatment of onychomycosis. Drug of choice for systemic infection In esophageal candidiasis the drug is active against some strains resistant to fluconazole. In acquired immunodeficiency syndrome associated histoplasmosis.

Voriconazole Is a broad spectrum antifungal agent, It is a co-drug of choice for treatment of invasive Aspergillosis.

Posaconazole is a new oral, broad spectrum antifungal agents in treatment of fungal infections caused by Mucor species.

Ketoconazo le Fluconazole Vorioconazol e Posaconazole Spectrum Narrow Expanded Expanded Expanded Route Oral Oral, IV Oral,IV Oral T ½ (hours) 6-9 30 24 66 CSF Penetration No Yes Yes Yes Elimination Hepatic Renal Hepatic Hepatic

4. Echinocandins include: Caspofungin Its unique antifungal action is by inhibiting the synthesis of β 1-2 glucan, a critical component of fungal cell walls leading to lysis and cell death. It is first-line therapy for the treatment of invasive aspergillosis It is used IV once daily. Half life is 9-11 hours

Caspofungin: Licensed for empiric antifungal therapy during febrile neutropenia Micafungin is licensed for prophylaxis of candida infections in bone marrow transplant patients

Cutaneous Mycotic Infections Fungi that cause superficial skin infections are called dermatophytes. These tinea infections are classified by the site of their infection, such as tinea pedis, which refers to an infection of the feet.

The three different fungi that cause the majority of cutaneous infections are Trichophyton, Microsporum, Epidermophyton These pathogens have a high affinity for keratinized tissue such as skin, hair, and nails.

Drugs for Cutaneous Mycotic Infections 1. Squalene epoxidase inhibitor: Terbinafine 2. Griseofulvin 3. Nystatin 4. Imidazoles 5. Ciclopirox 6. Tolnaftate

1. Squalene epoxidase inhibitors Act by inhibiting squalene epoxidase, resulting in the blocking of the biosynthesis of ergosterol which is an essential component of fungal cell membrane.

Terbinafine (fungicidal) Inhibits a fungal enzyme, squalene epoxidase. It cause accumulation of toxic levels of squalene, which interfere with ergosterol synthesis. It is accumulated in keratin, is much more effective than griseofulvin in onychomycosis and require shorter duration of therapy (3 months).

2. Griseofulvin (fungistatic) Oral absorption is enhanced by high-fat food. In treatment of dermatophytic infections of nails Griseofulvin requires 6-12 months duration of therapy, is dependent on the rate of replacement of healthy skin or nails. It accumulates in newly synthesized, keratin-containing tissue where it causes disruption of the mitotic spindle and inhibition of fungal mitosis.

3. Nystatin Is a polyene antibiotic, and its structure, chemistry, mechanism of action, and resistance resemble those of amphotericin B. Use in topical treatment of Candida infections because of its systemic toxicity. The drug is negligibly absorbed from the GIT Used orally for the treatment of oral candidiasis.

4. Imidazoles are azole derivatives include Miconazole, Clotrimazole, Terconazole, Econazole Are topically active drugs for vulvovaginal candidiasis, contact dermatitis.

5.Ciclopirox inhibits the transport of essential elements in the fungal cell, disrupting the synthesis of DNA, RNA, and protein. Ciclopirox 1% shampoo for treatment of seborrheic dermatitis.

6. Tolnaftate It is used to treat tinea pedis, tinea cruris, tinea corporis It is available as a 1% solution, cream & powder